Artec Bio
Artec Bio is a developer of next-generation protein degradation drugs
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Artec Bio is a developer of next-generation protein degradation drugs
Artec Bio's investors include CAS Star, Enran Chuangtou, Furong Capital, Shanghai Biomedical Industrial Equity Investment Fund.
Artec Bio most recently raised Series A in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 2, 2026 | Series A | CAS Star, Enran Chuangtou, Furong Capital, Shanghai Biomedical Industrial Equity Investment Fund |